Live data · NADAC + Part D CY24 · reviewed daily

Fluphenazine (Fluphenazine Hydrochoride)

First FDA approval1988-08-25
Generic availableYes · 22 mfrs
Shortage statusDiscontinued
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$39.3M in CY2024 Part D spend327K claims · 46K beneficiaries · 329 plans surveyed

Lowest NADAC
$0.121/unit
20 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.147
Across all dosage forms in distribution.
Highest NADAC
$0.148
Range is tight.
Plans with PA
373 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema9 entries indexed · 4 visible
What is Fluphenazine used for?

Fluphenazine is tracked in Medicare Part D. Specific indication information is not available in our current dataset.

Is there a generic for Fluphenazine?

Yes. 70 ANDAs filed at FDA, 22 generic manufacturers currently shipping.

How much does my plan pay for Fluphenazine?

Across 329 Part D plans, Fluphenazine averages $0.147/unit (NADAC). Lowest available: $0.121/unit. Highest in distribution: $0.148/unit.

Is Fluphenazine on the FDA shortage list?

Fluphenazine has been discontinued by its manufacturer(s).

5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Sources · every number above traces back.

Last refresh15 Oct 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.